share_log

Insiders At LifeStance Health Group Sold US$7.6m In Stock, Alluding To Potential Weakness

Insiders At LifeStance Health Group Sold US$7.6m In Stock, Alluding To Potential Weakness

LifeStance Health Group的內部人士出售了760萬美元的股票,暗示了潛在的疲軟
Simply Wall St ·  05/06 21:48

Many LifeStance Health Group, Inc. (NASDAQ:LFST) insiders ditched their stock over the past year, which may be of interest to the company's shareholders.   Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations.  However, if numerous insiders are selling, shareholders should investigate more.    

在過去的一年中,許多LifeStance Health Group, Inc.(納斯達克股票代碼:LFST)內部人士拋售了股票,這可能會引起該公司的股東的興趣。在評估內幕交易時,了解內部人士是否在買入通常更有幫助,因爲內幕賣出可以有多種解釋。但是,如果有許多內部人士出售,股東應該進行更多調查。

While insider transactions are not the most important thing when it comes to long-term investing,  we would consider it foolish to ignore insider transactions altogether.

儘管內幕交易並不是長期投資中最重要的事情,但我們認爲完全忽視內幕交易是愚蠢的。

The Last 12 Months Of Insider Transactions At LifeStance Health Group

LifeStance Health Group 過去 12 個月的內幕交易

In the last twelve months, the biggest single sale by an insider was when the CEO & Chairman, Kenneth Burdick, sold US$1.3m worth of shares at a price of US$6.28 per share.    That means that an insider was selling shares at  slightly  below the current price (US$6.66).  When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation.  However, while insider selling is sometimes discouraging, it's only a weak signal.   This single sale was just 6.8% of Kenneth Burdick's stake.    

在過去的十二個月中,內部人士最大的一次出售是首席執行官兼董事長肯尼思·伯迪克以每股6.28美元的價格出售了價值130萬美元的股票。這意味着一位內部人士正在以略低於當前價格(6.66美元)的價格出售股票。當內部人士以低於當前價格的價格出售時,這表明他們認爲較低的價格是公平的。這讓我們想知道他們如何看待最近(更高的)估值。但是,儘管內幕銷售有時令人沮喪,但這只是一個微弱的信號。此次出售僅佔肯尼思·伯迪克股份的6.8%。

In the last year LifeStance Health Group insiders didn't buy any company stock.    You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  By clicking on the graph below, you can see the precise details of each insider transaction!

去年,LifeStance Health Group內部人士沒有購買任何公司股票。你可以在下面看到過去 12 個月的內幕交易(公司和個人)的直觀描述。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

NasdaqGS:LFST Insider Trading Volume May 6th 2024

納斯達克GS: LFST 內幕交易量 2024 年 5 月 6 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

LifeStance Health Group Insiders Are Selling The Stock  

LifeStance Health 集團內部人士正在出售該股

The last quarter saw substantial insider selling of LifeStance Health Group shares.  In total,  insiders  sold US$4.0m worth of shares in that time, and we didn't record any purchases whatsoever.  This may suggest that some insiders think that the shares are not cheap.  

上個季度,LifeStance Health Group的股票遭到大量內幕拋售。在此期間,內部人士總共出售了價值400萬美元的股票,我們沒有記錄任何購買記錄。這可能表明一些內部人士認爲股票並不便宜。

Does LifeStance Health Group Boast High Insider Ownership?

LifeStance Health Group 是否擁有很高的內部所有權?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own.  I reckon it's a good sign if insiders own a significant number of shares in the company.   It's great to see that LifeStance Health Group insiders own 13% of the company, worth about US$328m.  I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.  

測試公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股份。我認爲,如果內部人士擁有該公司的大量股份,這是一個好兆頭。很高興看到LifeStance Health Group內部人士擁有該公司13%的股份,價值約3.28億美元。我喜歡看到這種程度的內部所有權,因爲它增加了管理層考慮股東最大利益的機會。

So What Does This Data Suggest About LifeStance Health Group Insiders?

那麼,這些數據對LifeStance Health Group內部人士有什麼啓示呢?

Insiders  sold stock recently, but they haven't been buying.     Looking to the last twelve months, our data doesn't show any insider buying.    It is good to see high insider ownership, but the insider selling leaves us cautious.      While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision.     You'd be interested to know, that we found 3 warning signs for LifeStance Health Group and we suggest you have a look.  

內部人士最近出售了股票,但他們一直沒有買入。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。看到較高的內部所有權是件好事,但內幕拋售使我們持謹慎態度。雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決策之前,我們一定要考慮股票面臨的風險。你可能會有興趣知道,我們發現了LifeStance Health Group的3個警告信號,我們建議你去看看。

Of course LifeStance Health Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,LifeStance Health Group可能不是最好的買入股票。因此,您可能希望看到這個免費的高質量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論